Fundraising Fox
Achillion Pharmaceuticals, Inc.
Founded 1992 · 5,159 employees on LinkedIn · 4 known investors
Find your way into Achillion Pharmaceuticals, Inc.
Sign up to see every warm intro you have to Achillion Pharmaceuticals, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Achillion Pharmaceuticals, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Achillion conducts research and development focused on addressing rare disease challenges through investigation of new therapeutic targets, modalities, and technologies. The company serves rare disease patients and their families globally.
Investors · 4
Connecticut Innovationslisted by Connecticut InnovationsNew Haven · $500K – $2M
How we know: Connecticut Innovations's portfolio page · Not right? Tell us
SV Health Investorslisted by SV Health InvestorsLondon · $1M – $20M
How we know: SV Health Investors's portfolio page · Not right? Tell us
Domain AssociatesreportedPrinceton · $200K – $15M
How we know: a partner's Signal profile · Not right? Tell us
In the news
Frequently asked questions
- What does Achillion Pharmaceuticals, Inc. do?
- Achillion conducts research and development focused on addressing rare disease challenges through investigation of new therapeutic targets, modalities, and technologies. The company serves rare disease patients and their families globally.
- Who are Achillion Pharmaceuticals, Inc.'s investors?
- Achillion Pharmaceuticals, Inc.'s investors include Connecticut Innovations, Pappas Capital, SV Health Investors, Domain Associates.